Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A french multicenter study
Chantal Fossat(Hôpital de la Timone), Richard Garand(Inserm), Francine Garnache‐Ottou(Inserm), Emilienne Kühlein(Centre Hospitalier Universitaire de Toulouse), André Baruchel(Université Paris Cité), Chantal Brouzes, Adriana Pleșa(Hospices Civils de Lyon), Marie‐Christine Jacob(Centre National de la Recherche Scientifique), Norbert Ifrah(Institut National du Cancer), Vahid Asnafi(Hôpital Necker-Enfants Malades), Isabelle Arnoux(Johannes Gutenberg University Mainz), Nelly Robillard, Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Elizabeth Macintyre(Inserm), Hervé Dombret(University of London Institute in Paris), Mikaël Roussel(Inserm), Jean Tkaczuk(Centre Hospitalier Universitaire de Toulouse)
Cited by 48
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k